Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery - A review

被引:165
作者
Zhu, Jieyu [1 ]
Tang, Xudong [1 ]
Jia, Yan [2 ]
Ho, Chi-Tang [1 ]
Huang, Qingrong [1 ]
机构
[1] Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA
[2] Beijing Technol & Business Univ, Sch Sci, Key Lab Cosmet China Natl Light Ind, Beijing, Peoples R China
关键词
Hyaluronic acid; Topical/transdermal delivery; Skin permeation; Hydrogel; Nano/micro-emulsion; Prodrug; Microneedle; Liposome/hyalurosome; ENHANCED TOPICAL DELIVERY; DRUG-DELIVERY; IN-VITRO; TRANSDERMAL DELIVERY; SKIN PENETRATION; DERMAL DELIVERY; SMART APPROACH; RECEPTOR; TISSUE; MICRONEEDLES;
D O I
10.1016/j.ijpharm.2020.119127
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this review is to introduce the functionalities of hyaluronic acid (HA) and its potential application as an effective carrier for topical/transdermal delivery. Specifically, several delivery mechanisms of HA were summarized here in order to explain its potential permeation-enhancing roles for the skin, which includes receptor-based delivery pathway, skin hydration, hydrophobic interaction with stratum corneum, bioadhesive properties, and viscoelastic properties. To achieve the optimum delivery efficacy for bioactive compounds at different target layers of the skin, HA with various molecular weights and chemical modifications were applied to design different delivery systems, including hydrogel, nanoemulsion, microemulsion, prodrug, microneedle, liposome/hyalurosome. Delivery efficacy has been evaluated using in vitro Franz Cell Diffusion method and/or in vivo animal models. Throughout this review, it was confirmed that HA could be an effective carrier for both topical and transdermal deliveries due to its unique viscoelasticity, biocompatibility, biodegradability, non-immunogenicity, and biomedical benefits for the skin.
引用
收藏
页数:10
相关论文
共 86 条
  • [1] A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee
    Adams, ME
    Lussier, AJ
    Peyron, JG
    [J]. DRUG SAFETY, 2000, 23 (02) : 115 - 130
  • [2] Hydrogel: Preparation, characterization, and applications: A review
    Ahmed, Enas M.
    [J]. JOURNAL OF ADVANCED RESEARCH, 2015, 6 (02) : 105 - 121
  • [3] Allemann IB, 2008, CLIN INTERV AGING, V3, P629
  • [4] [Anonymous], DRUG DISCOV TODAY
  • [5] [Anonymous], 2007, CIBA FDN S 143 BIOL, DOI DOI 10.1002/9780470513774.CH2
  • [6] CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE
    ARUFFO, A
    STAMENKOVIC, I
    MELNICK, M
    UNDERHILL, CB
    SEED, B
    [J]. CELL, 1990, 61 (07) : 1303 - 1313
  • [7] Balazs E. A., 1993, BIOTECHNOLOGICAL POL, P41
  • [8] Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery
    Barbault-Foucher, S
    Gref, R
    Russo, P
    Guechot, J
    Bochot, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) : 365 - 375
  • [9] Azelaic acid-loaded nanoemulsion with hyaluronic acid - a new strategy to treat hyperpigmentary skin disorders
    Berlitz, Simone Jacobus
    De Villa, Damie
    Maschmann Inacio, Luiz Augusto
    Davies, Samuel
    Zatta, Kelly Cristine
    Guterres, Silvia Staniscuaski
    Kulkamp-Guerreiro, Irene Clemes
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (04) : 642 - 650
  • [10] Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis
    Bourguignon, Lilly Y. W.
    Ramez, Mohamed
    Gilad, Eli
    Singleton, Patrick A.
    Man, Mao-Qiang
    Crumrine, Debra A.
    Elias, Peter M.
    Feingold, Kenneth R.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (06) : 1356 - 1365